相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management
Hedi L. Claahsen-van der Grinten et al.
ENDOCRINE REVIEWS (2022)
DNA sequencing: an overview of solid-state and biological nanopore-based methods
Mohammad M. Mohammadi et al.
BIOPHYSICAL REVIEWS (2022)
Single-molecule nanopore sequencing reveals extreme target copy number heterogeneity in arylomycin-resistant mutants
Hany S. Girgis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras
Qizong Lao et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2021)
Reassessment of predictive values of ACTH-stimulated serum 21-deoxycortisol and 17-hydroxyprogesterone to identify CYP21A2 heterozygote carriers and nonclassic subjects
Flavia A. Costa-Barbosa et al.
CLINICAL ENDOCRINOLOGY (2021)
A new synonymous variant involving an mRNA splicing site in CYP21A2 detected in 12 unrelated patients with deficiency of 21-hydroxylase
Maria Arriba et al.
CLINICAL GENETICS (2021)
Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia
Wencui Wang et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2021)
PB-Motif-A Method for Identifying Gene/Pseudogene Rearrangements With Long Reads: An Application to CYP21A2 Genotyping
Zachary Stephens et al.
FRONTIERS IN GENETICS (2021)
Genetic Analysis of Pediatric Primary Adrenal Insufficiency of Unknown Etiology: 25 Years' Experience in the UK
Federica Buonocore et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Clinical application of a novel next generation sequencing assay forCYP21A2gene in 310 cases of 21-hydroxylase congenital adrenal hyperplasia from India
Priyanka Gangodkar et al.
ENDOCRINE (2021)
Solid-state nanopores towards single-molecule DNA sequencing
Yusuke Goto et al.
JOURNAL OF HUMAN GENETICS (2020)
21-Hydroxylase deficiency: Mutational spectrum and Genotype-Phenotype relations analyses by next-generation sequencing and multiplex ligation-dependent probe amplification
Ihsan Turan et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2020)
Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia
Valentina Guarnotta et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)
11-Oxygenated androgens in health and disease
Adina F. Turcu et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
Sabina Baumgartner-Parzer et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
Non-Classic Disorder of Adrenal Steroidogenesis and Clinical Dilemmas in 21-Hydroxylase Deficiency Combined with Backdoor Androgen Pathway. Mini-Review and Case Report
Marta Suminska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Success of a Screening Program Is Largely Dependent on Close Collaboration between the Laboratory and the Clinical Follow-Up of the Patients
Svetlana Lajic et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2020)
High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening
Patricia S. Castro et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2019)
Novel non-classic CYP21A2 variants, including combined alleles, identified in patients with congenital adrenal hyperplasia
Leif Karlsson et al.
CLINICAL BIOCHEMISTRY (2019)
Issues with the Detection of Large Genomic Rearrangements in Molecular Diagnosis of 21-Hydroxylase Deficiency
Paola Concolino
MOLECULAR DIAGNOSIS & THERAPY (2019)
Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
Sarantis Livadas et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
Duarte Pignatelli et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Carriers of a Classic CYP21A2 Mutation Have Reduced Mortality: A Population-Based National Cohort Study
Anna Nordenstrom et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Assisted Reproduction in Congenital Adrenal Hyperplasia
Anastasios Chatziaggelou et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Genetics of congenital adrenal hyperplasia and genotype-phenotype correlation
Mithra L. Narasimhan et al.
FERTILITY AND STERILITY (2019)
CYP21A2 mutation update: Comprehensive analysis of databases and published genetic variants
Leandro Simonetti et al.
HUMAN MUTATION (2018)
News about the genetics of congenital primary adrenal insufficiency
Florence Roucher-Boulez et al.
ANNALES D ENDOCRINOLOGIE (2018)
MECHANISMS IN ENDOCRINOLOGY Rare defects in adrenal steroidogenesis
Walter L. Miller
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome
Walter L. Miller et al.
HORMONE RESEARCH IN PAEDIATRICS (2018)
Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene
Paola Concolino et al.
MOLECULAR DIAGNOSIS & THERAPY (2018)
Newborn screening of congenital adrenal hyperplasia
Elena Dulín Iñiguez et al.
Endocrinologia Diabetes y Nutricion (2018)
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline
Phyllis W. Speiser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
MECHANISMS IN ENDOCRINOLOGY Update on pathogenesis of primary adrenal insufficiency: beyond steroid enzyme deficiency and autoimmune adrenal destruction
Christa E. Flueck
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women
Enrico Carmina et al.
HUMAN REPRODUCTION UPDATE (2017)
Congenital adrenal hyperplasia
Diala El-Maouche et al.
LANCET (2017)
Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction
Daniel F. de Carvalho et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Cross-reactivity of adrenal steroids with aldosterone may prevent the accurate diagnosis of congenital adrenal hyperplasia
Hale Unver Tuhan et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2015)
Research Resource: Correlating Human Cytochrome P450 21A2 Crystal Structure and Phenotypes of Mutations in Congenital Adrenal Hyperplasia
Pradeep S. Pallan et al.
MOLECULAR ENDOCRINOLOGY (2015)
A de novo mutation in CYP21A2 gene in a case of in vitro fertilization
Roseane Lopes da Silva-Grecco et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2015)
Biochemical and genetic diagnosis of 21-hydroxylase deficiency
Henrik Falhammar et al.
ENDOCRINE (2015)
Fertility in patients with congenital adrenal hyperplasia
David E. Reichman et al.
FERTILITY AND STERILITY (2014)
Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia Using Cell-Free Fetal DNA in Maternal Plasma
Maria I. New et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia
Ingeborg Bronstad et al.
ENDOCRINE CONNECTIONS (2014)
Comprehensive Mutation Analysis of the CYP21A2 Gene An Efficient Multistep Approach to the Molecular Diagnosis of Congenital Adrenal Hyperplasia
Zhi Xu et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia
Shozeb Haider et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
Maria I. New et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study
Sebastian Gidlof et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Junction Site Analysis of Chimeric CYP21A1P/CYP21A2 Genes in 21-Hydroxylase Deficiency
Wuyan Chen et al.
CLINICAL CHEMISTRY (2012)
p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients
Paola Concolino et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Sequence Analysis of CYP21A1P in a German Population to Aid in the Molecular Biological Diagnosis of Congenital Adrenal Hyperplasia
Cumhur Cantuerk et al.
CLINICAL CHEMISTRY (2011)
Chimeric CYP21A1P/CYP21A2 genes identified in Czech patients with congenital adrenal hyperplasia
Zuzana Vrzalova et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2011)
Usefulness of molecular analysis in the differential diagnosis of congenital 21-hidroxylase deficiency detected in neonatal screening
Leandro Soriano Guillen et al.
MEDICINA CLINICA (2011)
Virilizing congenital adrenogenital syndrome with a de novo I172N mutation: Study of a new case
I. Diez Lopez et al.
ANALES DE PEDIATRIA (2010)
Phenotype-Genotype Correlations of 13 Rare CYP21A2 Mutations Detected in 46 Patients Affected with 21-Hydroxylase Deficiency and in One Carrier
V. Tardy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
Phyllis W. Speiser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Simple virilizing forms of congenital adrenal hyperplasia: adaptation and prospective validation of the molecular screening
Jose Luis Santome Collazo et al.
MEDICINA CLINICA (2010)
Carrier detection and prenatal diagnosis of congenital adrenal hyperplasia must identify 'apparently mild' CYP21A2 alleles which associate neonatal salt-wasting disease
Begona Ezquieta et al.
PRENATAL DIAGNOSIS (2010)
Genetics of congenital adrenal hyperplasia
Nils Krone et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form
Paola Concolino et al.
BMC MEDICAL GENETICS (2009)
Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia
E. L. Silveira et al.
CLINICAL GENETICS (2009)
Monogenic and Polygenic Models Detected in Steroid 21-Hydroxylase Deficiency-Related Paediatric Hyperandrogenism
B. Ezquieta et al.
HORMONE RESEARCH (2009)
Extraadrenal 21-Hydroxylation by CYP2C19 and CYP3A4: Effect on 21-Hydroxylase Deficiency
Larissa G. Gomes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Duplications of the Functional CYP21A2 Gene Are Primarily Restricted to Q318X Alleles: Evidence for a Founder Effect
S. Kleinle et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Comparative Performance of Single Nucleotide Polymorphism and Microsatellite Markers for Population Genetic Analysis
Brad S. Coates et al.
JOURNAL OF HEREDITY (2009)
Congenital Adrenal Hyperplasia Because of 21-Hydroxylase Deficiency A Genetic Disorder of Interest to Obstetricians and Gynecologists
Eftihios Trakakis et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2009)
C4B null alleles are not associated with genetic polymorphisms in the adjacent gene CYP21A2 in autism
Thayne L. Sweeten et al.
BMC MEDICAL GENETICS (2008)
47th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE)
Hormone Research in Paediatrics (2008)
High Frequency of Copy Number Variations and Sequence Variants at CYP21A2 Locus: Implication for the Genetic Diagnosis of 21-Hydroxylase Deficiency
Silvia Parajes et al.
PLOS ONE (2008)
Gene duplications in 21-hydroxyllase deficiency:: the importance of accurate molecular diagnosis in carrier detection and prenatal diagnosis
B. Ezquieta et al.
PRENATAL DIAGNOSIS (2006)
Molecular model of human CYP21 based on mammalian CYP2C5: Structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia
Tiina Robins et al.
MOLECULAR ENDOCRINOLOGY (2006)
Hyperandrogenism in carriers of CYP21 mutations: the role of genotype
Osnat Admoni et al.
CLINICAL ENDOCRINOLOGY (2006)
CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia:: Identification of two novel mutations and characterization of four different partial gene conversions
A Friaes et al.
MOLECULAR GENETICS AND METABOLISM (2006)
Prevalence of frequent recessive diseases in the Spanish population through DNA analyses on samples from the neonatal screening
B Ezquieta et al.
MEDICINA CLINICA (2005)
21-hydroxylase deficiency: an exemplary model of the contribution of molecular biology in the understanding and management of the disease
MG Forest et al.
ANNALES D ENDOCRINOLOGIE (2005)
Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population
SM Baumgartner-Parzer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation
RS Araujo et al.
CLINICAL ENDOCRINOLOGY (2005)
Neonatal salt-wasting and 11 β-hydroxylase deficiency in a child carrying a homozygous deletion hybrid CYP11B2 (aldosterone synthase)-CYP11B1 (11 β-hydroxylase)
B Ezquieta et al.
CLINICAL GENETICS (2004)
Inborn errors of adrenal steroidogenesis
MI New
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency:: characteristics of three unusual haplotypes
PFJ Koppens et al.
HUMAN GENETICS (2002)
Genetic sophistication of human complement components C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex
EK Chung et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect
A Elisa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Gene conversion (655G splicing mutation) and the founder effect (Gln318Stop) contribute to the most frequent severe point mutations in congenital adrenal hyperplasia (21-hydroxylase deficiency) in the Spanish population
B Ezquieta et al.
CLINICAL GENETICS (2002)
Non-classical 21-hydroxylase deficiency in children: association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations
B Ezquieta et al.
ACTA PAEDIATRICA (2002)
Major histocompatibility complex (MHC)-linked microsatellite markers in a founder population
K Karell et al.
TISSUE ANTIGENS (2000)
分享论文
